Novartis Ag (NVS) Cash & Current Investments (2009 - 2026)
Novartis Ag's Cash & Current Investments was $505 million in Q3 2026, down 94.8% from $9.75 billion a year earlier and down 93.4% from the prior quarter.
Powered by 
Analysis
Novartis Ag (NVS) Cash & Current Investments (2009 - 2026) Analysis & Trends
At the end of FY2025, Cash & Current Investments at Novartis Ag came in at $11.59 billion, down 13.9% from FY2024.
- Cash & Current Investments has now declined for four consecutive years, with a five-year compound annual growth rate of 0.0% (FY2020 to FY2025).
- In earlier years, Cash & Current Investments was $13.46 billion in FY2024 (-6.7%), $14.43 billion in FY2023 (-23.8%), $18.93 billion in FY2022 (-33.2%) and $28.33 billion in FY2021 (+145.0%).
- The Q3 2026 figure marks the lowest quarterly Cash & Current Investments in data going back to Q1 2009.
- Compared with a year earlier, Cash & Current Investments was higher in 1 of the last eight quarters, with an average decline of 22.7%.
- The best year-over-year quarter for Cash & Current Investments over five years was Q1 2022 (growth of 361.5%); the worst was Q3 2026 (a decline of 94.8%).
- Per Business Quant data, NVS's Cash & Current Investments in the three quarters before Q3 2026 was $7.69 billion (Q2 2026), $6.98 billion (Q1 2026) and $11.59 billion (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | 9.65 Bn |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | 505.00 Mn |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | 14.27 Bn |
| 10 | Vertex Pharmaceuticals | 138.73 Bn | 110.72 Bn | 2.91 Bn | 6.30 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 505.00 Mn |
| Jun 30, 2026 | 7.69 Bn |
| Mar 31, 2026 | 6.98 Bn |
| Dec 31, 2025 | 11.59 Bn |
| Sep 30, 2025 | 9.75 Bn |
| Jun 30, 2025 | 7.00 Bn |
| Mar 31, 2025 | 7.20 Bn |
| Dec 31, 2024 | 13.46 Bn |
| Sep 30, 2024 | 14.02 Bn |
| Jun 30, 2024 | 8.44 Bn |
| Mar 31, 2024 | 9.69 Bn |
| Dec 31, 2023 | 14.43 Bn |
| Sep 30, 2023 | 12.70 Bn |
| Jun 30, 2023 | 11.17 Bn |
| Mar 31, 2023 | 12.26 Bn |
| Dec 31, 2022 | 18.93 Bn |
| Sep 30, 2022 | 19.10 Bn |
| Jun 30, 2022 | 19.76 Bn |
| Mar 31, 2022 | 18.81 Bn |
| Dec 31, 2021 | 28.33 Bn |
API Access
Novartis Ag Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=NVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "NVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=NVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();